Scienture (SCNX) Competitors $1.03 -0.01 (-0.96%) Closing price 04:00 PM EasternExtended Trading$1.03 0.00 (-0.39%) As of 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock SCNX vs. WGRX, GDC, NHTC, RAVE, COSM, HYFM, TLIH, LTCH, DTCK, and BANLShould you be buying Scienture stock or one of its competitors? The main competitors of Scienture include Wellgistics Health (WGRX), GD Culture Group (GDC), Natural Health Trends (NHTC), Rave Restaurant Group (RAVE), Cosmos Health (COSM), Hydrofarm Holdings Group (HYFM), Ten-League International (TLIH), Latch (LTCH), Davis Commodities (DTCK), and CBL International (BANL). These companies are all part of the "wholesale" industry. Scienture vs. Its Competitors Wellgistics Health GD Culture Group Natural Health Trends Rave Restaurant Group Cosmos Health Hydrofarm Holdings Group Ten-League International Latch Davis Commodities CBL International Scienture (NASDAQ:SCNX) and Wellgistics Health (NASDAQ:WGRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation. Is SCNX or WGRX more profitable? Wellgistics Health has a net margin of 0.00% compared to Scienture's net margin of -10,364.22%. Wellgistics Health's return on equity of 0.00% beat Scienture's return on equity.Company Net Margins Return on Equity Return on Assets Scienture-10,364.22% -24.47% -19.30% Wellgistics Health N/A N/A N/A Which has better earnings and valuation, SCNX or WGRX? Scienture has higher earnings, but lower revenue than Wellgistics Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScienture$140K118.67$9.07MN/AN/AWellgistics Health$18.13M7.19-$6.86MN/AN/A Do institutionals and insiders hold more shares of SCNX or WGRX? 5.7% of Scienture shares are owned by institutional investors. 49.7% of Scienture shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media refer more to SCNX or WGRX? In the previous week, Wellgistics Health had 3 more articles in the media than Scienture. MarketBeat recorded 5 mentions for Wellgistics Health and 2 mentions for Scienture. Scienture's average media sentiment score of 1.23 beat Wellgistics Health's score of 0.69 indicating that Scienture is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Scienture 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Wellgistics Health 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryScienture and Wellgistics Health tied by winning 5 of the 10 factors compared between the two stocks. Get Scienture News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCNX vs. The Competition Export to ExcelMetricScientureMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.61M$2.48B$5.74B$9.78BDividend YieldN/A1.67%4.40%4.04%P/E RatioN/A22.5330.8326.39Price / Sales118.67506.55382.9086.63Price / CashN/A178.3537.7259.11Price / Book0.216.2910.106.62Net Income$9.07M$32.94M$3.26B$265.42M7 Day Performance-3.74%2.27%3.90%3.58%1 Month Performance-48.24%1.06%3.73%0.46%1 Year PerformanceN/A5.65%37.68%19.41% Scienture Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCNXScientureN/A$1.03-1.0%N/AN/A$16.61M$140K0.00N/APositive NewsGap UpWGRXWellgistics HealthN/A$0.87+16.1%N/AN/A$56.79M$28.99M0.0031GDCGD Culture Group0.8627 of 5 stars$3.05+2.0%N/A-29.6%$50.22MN/A-4.1260News CoveragePositive NewsNHTCNatural Health Trends1.3808 of 5 stars$4.22-1.2%N/A-36.1%$49.16M$42.96M140.71140Positive NewsRAVERave Restaurant Group1.7574 of 5 stars$2.74-1.1%N/A+80.9%$39.37M$12.15M14.4220Positive NewsCOSMCosmos Health1.1809 of 5 stars$0.83-2.1%N/A-30.5%$25.55M$54.43M-0.81100HYFMHydrofarm Holdings Group1.2896 of 5 stars$4.60+1.3%N/A-18.8%$21.43M$161.10M-0.34840Positive NewsTLIHTen-League InternationalN/A$0.64-11.7%N/AN/A$21.14MN/A0.0064Positive NewsGap DownLTCHLatchN/A$0.12flatN/A-68.9%$19.78M$48.39M0.00420Gap DownDTCKDavis Commodities0.3695 of 5 stars$0.80+1.3%N/A-42.4%$19.35M$132.37M0.0022High Trading VolumeBANLCBL International0.5196 of 5 stars$0.68-0.5%N/A-38.6%$18.66M$592.52M0.0035Positive NewsGap Down Related Companies and Tools Related Companies WGRX Competitors GDC Competitors NHTC Competitors RAVE Competitors COSM Competitors HYFM Competitors TLIH Competitors LTCH Competitors DTCK Competitors BANL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCNX) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scienture Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scienture With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access